Keros Therapeutics (KROS) PT Raised to $27 at Oppenheimer
Tweet
Share
E-mailGet Alerts KROS Hot Sheet
Price: $11.63 -0.85%
Rating Summary:
8 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Rating Summary:
8 Buy, 7 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 7 | Down: 6 | New: 39
Join SI Premium – FREE
Oppenheimer analyst Andreas Argyrides raised the price target on Keros Therapeutics (NASDAQ: KROS) to $27.00 (from $23.00) while maintaining a Outperform rating.
You May Also Be Interested In
- Constellation Brands (STZ) PT Lowered to $145 at UBS on Softer Consumer Backdrop
- China Shenhua Energy (601088:CH) PT Raised to RMB53.60 at Citi
- IGO Limited (IGO.AU) (IPGDF) PT Lowered to AUD6.90 at RBC Capital
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
